Physician profile
Mark Louis Winkler
NPI 1689674343
$305,794.35
in general payments reported to CMS, 2019-2025
7 companies · $12K in 2025
The $12K reported for 2025 was more than what 97% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $165K · 2021: $18K · 2022: $23K · 2023: $5,468 · 2024: $63K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $76K · Food and Beverage: $2,065 · Travel and Lodging: $1,882.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $76,200.00 |
| Food and Beverage | $2,064.97 |
| Travel and Lodging | $1,882.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Canon Medical Systems USA, INC. | $303,881.79 | 2019-2025 | Canon INC., Pet-Ct Scanner, Ct Scanner Epsilon |
| Ge Healthcare | $1,050.26 | 2021-2025 | |
| Siemens Medical Solutions USA, INC. | $395.90 | 2019-2024 | Magnetom Free.Max |
| Hitachi Healthcare Americas Corp. | $206.83 | 2019-2020 | |
| Blue Earth Diagnostics | $121.81 | 2024 | |
| Fujifilm Healthcare Americas Corporation | $72.51 | 2022 | |
| Philips North America LLC | $65.25 | 2025 | Blueseal Xe/Se |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Winkler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.